Faecal microbial metabolites of proteolytic and saccharolytic fermentation in relation to degree of insulin resistance in adult individuals
In: Beneficial MicrobesSearch for other papers by M.A. González Hernández in
Current site
Google Scholar
Search for other papers by E.E. Canfora in
Current site
Google Scholar
Search for other papers by E.E. Blaak in
Current site
Google Scholar
The gut microbiota may affect host metabolic health through microbial metabolites. The balance between the production of microbial metabolites by saccharolytic and proteolytic fermentation may be an important determinant of metabolic health. Amongst the best-studied saccharolytic microbial metabolites are the short-chain fatty acids acetate, propionate and butyrate. However, human data on the role of other microbial fermentation by-products in metabolic health are greatly lacking. Therefore, we compared in a cross-sectional study the faecal microbial metabolites (caproate, lactate, valerate, succinate, and the branched-chain fatty acids (BCFA) (isobutyrate, isovalerate)) between insulin sensitive (homeostatic model assessment of insulin resistance (HOMA-IR), HOMA-IR<1.85, IS) and insulin resistant (HOMA-IR>1.85, IR) individuals. Additionally, we assessed the relationships between faecal metabolites and markers of metabolic health including fasting glucose, insulin, free fatty acids, insulin resistance (HOMA-IR) and fasting substrate oxidation in 86 individuals with a wide range of body mass index. Faecal metabolite concentrations did not significantly differ between IS and IR. Furthermore, there were no associations between microbial metabolites and metabolic health markers, except for a slight positive association of isovalerate with carbohydrate oxidation (E%, std β 0.194, P=0.011) and fat oxidation (E%, std β -0.075, P=0.047), also after adjustment for age, sex and BMI. In summary, faecal caproate, lactate, valerate, succinate, and BCFA (isobutyrate, isovalerate) were not different between IR and IS individuals, nor was there any association between these faecal metabolites and parameters of metabolic health. Further human intervention studies are warranted to investigate the role of these microbially-derived fermentation products and their kinetics in metabolic health and insulin sensitivity.
-
Aragonès, G., Colom-Pellicer, M., Aguilar, C., Guiu-Jurado, E., Martínez, S., Sabench, F., Antonio Porras, J., Riesco, D., Del Castillo, D., Richart, C. and Auguet, T., 2020. Circulating microbiota-derived metabolites: a liquid biopsy? International Journal of Obesity 44: 875-885. https://doi.org/10.1038/s41366-019-0430-0
-
Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.-M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H.B., Nielsen, T., Pons, N., Poulain, J., Qin, J., Sicheritz-Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E.G. Wang, J., Guarner, F., Pedersen, O., De Vos, W.M., Brunak, S., Doré, J., Antolín, M., Artiguenave, F., Blottiere, H.M., Almeida, M., Brechot, C., Cara, C., Chervaux, C., Cultrone, A., Delorme, C., Denariaz, G., Dervyn, R., Foerstner, K.U., Friss, C., Van de Guchte, M., Guedon, E., Haimet, F., Huber, W., Van Hylckama-Vlieg, J., Jamet, A., Juste, C., Kaci, G., Knol, J., Kristiansen, K., Lakhdari, O., Layec, S., Le Roux, K., Maguin, E., Mérieux, A., Melo Minardi, R., M’Rini, C., Muller, J., Oozeer, R., Parkhill, J., Renault, P., Rescigno, M., Sanchez, N., Sunagawa, S., Torrejon, A., Turner, K., Vandemeulebrouck, G., Varela, E., Winogradsky, Y., Zeller, G., Weissenbach, J., Ehrlich, S.D., Bork, P. and the MetaHIT consortium, 2011. Enterotypes of the human gut microbiome. Nature 473: 174-180. https://doi.org/10.1038/nature09944
-
Blachier, F., Beaumont, M., Portune, K.J., Steuer, N., Lan, A., Audebert, M., Khodorova, N., Andriamihaja, M., Airinei, G., Benamouzig, R., Davila, A.-M., Armand, L., Rampelli, S., Brigidi, P., Tomé, D., Claus, S.P. and Sanz, Y., 2019. High-protein diets for weight management: interactions with the intestinal microbiota and consequences for gut health. A position paper by the my new gut study group. Clinical Nutrition 38: 1012-1022. https://doi.org/10.1016/j.clnu.2018.09.016
-
Bouter, K., Bakker, G.J., Levin, E., Hartstra, A.V., Kootte, R.S., Udayappan, S.D., Katiraei, S., Bahler, L., Gilijamse, P.W., Tremaroli, V., Stahlman, M., Holleman, F., Van Riel, N.A.W., Verberne, H.J., Romijn, J.A., Dallinga-Thie, G.M., Serlie, M.J., Ackermans, M.T., Kemper, E.M., Willems van Dijk, K., Backhed, F., Groen, A.K. and Nieuwdorp, M., 2018. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects. Clinical and Translational Gastroenterology 9: 155-155. https://doi.org/10.1038/s41424-018-0025-4
-
Canfora, E.E. and Blaak, E.E., 2018. Beta glucan and acetate production. Clinicaltrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT03714646
-
Canfora, E.E., Jocken, J.W. and Blaak, E.E., 2015. Short-chain fatty acids in control of body weight and insulin sensitivity. Nature Reviews Endocrinology 11: 577-591. https://doi.org/10.1038/nrendo.2015.128
-
Canfora, E.E., Meex, R.C.R., Venema, K. and Blaak, E.E., 2019. Gut microbial metabolites in obesity, NAFLD and T2DM. Nature Reviews Endocrinology 15: 261-273. https://doi.org/10.1038/s41574-019-0156-z
-
Castaner, O., Goday, A., Park, Y.-M., Lee, S.-H., Magkos, F., Shiow, S.-A.T.E. and Schröder, H., 2018. The gut microbiome profile in obesity: a systematic review. International Journal of Endocrinology 2018: 4095789. https://doi.org/10.1155/2018/4095789
-
Da Silva, H.E., Teterina, A., Comelli, E.M., Taibi, A., Arendt, B.M., Fischer, S.E., Lou, W. and Allard, J.P., 2018. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. Scientific Reports 8: 1466. https://doi.org/10.1038/s41598-018-19753-9
-
De Weir, J.B., 1949. New methods for calculating metabolic rate with special reference to protein metabolism. Journal of Physiology 109: 1-9.
'New methods for calculating metabolic rate with special reference to protein metabolism ' () 109 Journal of Physiology : 1 -9.
-
Den Besten, G., Van Eunen, K., Groen, A.K., Venema, K., Reijngoud, D.-J. and Bakker, B.M., 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 54: 2325-2340. https://doi.org/10.1194/jlr.R036012
-
Feng, W., Ao, H. and Peng, C., 2018. Gut microbiota, short-chain fatty acids, and herbal medicines. Frontiers in Pharmacology 9: 1354. https://doi.org/10.3389/fphar.2018.01354
-
Fernandes, J., Su, W., Rahat-Rozenbloom, S., Wolever, T.M.S. and Comelli, E.M., 2014. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutrition and Diabetes 4: e121. https://doi.org/10.1038/nutd.2014.23
-
Frayn, K.N., 1983. Calculation of substrate oxidation rates in vivo from gaseous exchange. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 55: 628-634. https://doi.org/10.1152/jappl.1983.55.2.628
-
Gannon, N.P., Schnuck, J.K. and Vaughan, R.A., 2018. BCAA metabolism and insulin sensitivity – dysregulated by metabolic status? Molecular Nutrition and Food Research 62: e1700756. https://doi.org/10.1002/mnfr.201700756
-
Garcia-Villalba, R., Gimenez-Bastida, J.A., Garcia-Conesa, M.T., Tomas-Barberan, F.A., Carlos Espin, J. and Larrosa, M., 2012. Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples. Journal of Separation Science 35: 1906-1913. https://doi.org/10.1002/jssc.201101121
-
Granado-Serrano, A.B., Martín-Garí, M., Sánchez, V., Riart Solans, M., Berdún, R., Ludwig, I.A., Rubió, L., Vilaprinyó, E., Portero-Otín, M. and Serrano, J.C.E., 2019. Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia. Scientific Reports 9: 1772. https://doi.org/10.1038/s41598-019-38874-3
-
Hald, S., Schioldan, A.G., Moore, M.E., Dige, A., Lærke, H.N., Agnholt, J., Bach Knudsen, K.E., Hermansen, K., Marco, M.L., Gregersen, S. and Dahlerup, J.F., 2016. Effects of arabinoxylan and resistant starch on intestinal microbiota and short-chain fatty acids in subjects with metabolic syndrome: a randomised crossover study. PLoS ONE 11: e0159223. https://doi.org/10.1371/journal.pone.0159223
-
Hansen, A.M.B., Wium, C., Lee, S., Tierney, A.C., McCarthy, D., Roche, H.M., Drevon, C.A., Birkeland, K.I. and Gulseth, H.L., 2020. Substantial inter-individual variations in insulin secretion and sensitivity across the glucometabolic spectrum. Scandinavian Journal of Clinical and Laboratory Investigation 80: 282-290. https://doi.org/10.1080/00365513.2020.1730433
-
Heimann, E., Nyman, M., Pålbrink, A.-K., Lindkvist-Petersson, K. and Degerman, E., 2016. Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes. Adipocyte 5: 359-368. https://doi.org/10.1080/21623945.2016.1252011
-
Holscher, H.D., 2017. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8: 172-184. https://doi.org/10.1080/19490976.2017.1290756
-
Koh, A., De Vadder, F., Kovatcheva-Datchary, P. and Bäckhed, F., 2016. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165: 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
-
Koliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., Gavalko, Y., Dorofeyev, A., Romanenko, M., Tkach, S., Sineok, L., Lushchak, O. and Vaiserman, A., 2017. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiology 17: 120-120. https://doi.org/10.1186/s12866-017-1027-1
-
Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y.S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Björck, I. and Bäckhed, F., 2015. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metabolism 22: 971-982. https://doi.org/10.1016/j.cmet.2015.10.001
-
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., Perlemuter, G., Cassard-Doulcier, A.M. and Gerard, P., 2013. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62: 1787-1794. https://doi.org/10.1136/gutjnl-2012-303816
-
Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D. and Gordon, J.I., 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the USA 102: 11070-11075. https://doi.org/10.1073/pnas.0504978102
-
Lim, J., Henry, C.J. and Haldar, S., 2016. Vinegar as a functional ingredient to improve postprandial glycemic control-human intervention findings and molecular mechanisms. Molecular Nutrition and Food Research 60: 1837-1849. https://doi.org/10.1002/mnfr.201600121
-
Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V.D., Sokol, H., Doré, J., Corthier, G. and Furet, J.P., 2009. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiology 9: 123. https://doi.org/10.1186/1471-2180-9-123
-
Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. and Turner, R.C., 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. https://doi.org/10.1007/bf00280883
-
Mika, A., Stepnowski, P., Kaska, L., Proczko, M., Wisniewski, P., Sledzinski, M. and Sledzinski, T., 2016. A comprehensive study of serum odd- and branched-chain fatty acids in patients with excess weight. Obesity 24: 1669-1676. https://doi.org/10.1002/oby.21560
-
Müller, M., Canfora, E.E. and Blaak, E.E., 2018. Gastrointestinal transit time, glucose homeostasis and metabolic health: modulation by dietary fibers. Nutrients 10: 275. https://doi.org/10.3390/nu10030275
-
Müller, M., Hermes, G., Canfora, E., Holst, J., Zoetendal, E., Smidt, H., Troost, F., Schaap, F., Damink, S., Jocken, J., Lenaerts, K., Masclee, A. and Blaak, E., 2020. Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit. Gut Microbes 12: 1704141. https://doi.org/10.1080/19490976.2019.1704141
-
Müller, M., Hernández, M.A.G., Goossens, G.H., Reijnders, D., Holst, J.J., Jocken, J.W.E., Van Eijk, H., Canfora, E.E. and Blaak, E.E., 2019. Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans. Scientific Reports 9: 12515. https://doi.org/10.1038/s41598-019-48775-0
-
Nagpal, R., Mainali, R., Ahmadi, S., Wang, S., Singh, R., Kavanagh, K., Kitzman, D.W., Kushugulova, A., Marotta, F. and Yadav, H., 2018. Gut microbiome and aging: physiological and mechanistic insights. Nutrition and Healthy Aging 4: 267-285. https://doi.org/10.3233/NHA-170030
-
Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F., Haqq, A.M., Shah, S.H., Arlotto, M., Slentz, C.A., Rochon, J., Gallup, D., Ilkayeva, O., Wenner, B.R., Yancy Jr, W.S., Eisenson, H., Musante, G., Surwit, R.S., Millington, D.S., Butler, M.D. and Svetkey, L.P., 2009. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism 9: 311-326. https://doi.org/10.1016/j.cmet.2009.02.002
-
Ran-Ressler, R.R., Bae, S., Lawrence, P., Wang, D.H. and Brenna, J.T., 2014. Branched-chain fatty acid content of foods and estimated intake in the USA. British Journal of Nutrition 112: 565-572. https://doi.org/10.1017/s0007114514001081
-
Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., Muehlbauer, M.J., Ilkayeva, O., Semenkovich, C.F., Funai, K., Hayashi, D.K., Lyle, B.J., Martini, M.C., Ursell, L.K., Clemente, J.C., Van Treuren, W., Walters, W.A., Knight, R., Newgard, C.B., Heath, A.C. and Gordon, J.I., 2013. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214. https://doi.org/10.1126/science.1241214
-
Russell, W.R., Gratz, S.W., Duncan, S.H., Holtrop, G., Ince, J., Scobbie, L., Duncan, G., Johnstone, A.M., Lobley, G.E., Wallace, R.J., Duthie, G.G. and Flint, H.J., 2011. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. American Journal of Clinical Nutrition 93: 1062-1072. https://doi.org/10.3945/ajcn.110.002188
-
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N.A., Donus, C. and Hardt, P.D., 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195. https://doi.org/10.1038/oby.2009.167
-
Shen, J., Obin, M.S. and Zhao, L., 2013. The gut microbiota, obesity and insulin resistance. Molecular Aspects of Medicine 34: 39-58. https://doi.org/10.1016/j.mam.2012.11.001
-
Tang, Z.-Z., Chen, G., Hong, Q., Huang, S., Smith, H.M., Shah, R.D., Scholz, M. and Ferguson, J.F., 2019. Multi-omic analysis of the microbiome and metabolome in healthy subjects reveals microbiome-dependent relationships between diet and metabolites. Frontiers in Genetics 10: 454. https://doi.org/10.3389/fgene.2019.00454
-
Tiihonen, K., Ouwehand, A.C. and Rautonen, N., 2010. Effect of overweight on gastrointestinal microbiology and immunology: correlation with blood biomarkers. British Journal of Nutrition 103: 1070-1078. https://doi.org/10.1017/S0007114509992807
-
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031. https://doi.org/10.1038/nature05414
-
Van der Beek, C.M., Canfora, E.E., Kip, A.M., Gorissen, S.H.M., Olde Damink, S.W.M., Van Eijk, H.M., Holst, J.J., Blaak, E.E., Dejong, C.H.C. and Lenaerts, K., 2018. The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men. Metabolism 87: 25-35. https://doi.org/10.1016/j.metabol.2018.06.009
-
Vogelzangs, N., Van der Kallen, C.J.H., Van Greevenbroek, M.M.J., Van der Kolk, B.W., Jocken, J.W.E., Goossens, G.H., Schaper, N.C., Henry, R.M.A., Eussen, S.J.P.M., Valsesia, A., Hankemeier, T., Astrup, A., Saris, W.H.M., Stehouwer, C.D.A., Blaak, E.E., Arts, I.C.W. and the Diogenes Consortium., 2020. Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the Diogenes study and the Maastricht Study. International Journal of Obesity 44: 1376-1386. https://doi.org/10.1038/s41366-020-0565-z
-
Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., Sinha, R., Gilroy, E., Gupta, K., Baldassano, R., Nessel, L., Li, H., Bushman, F.D. and Lewis, J.D., 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105. https://doi.org/10.1126/science.1208344
-
Zhong, H., Penders, J., Shi, Z., Ren, H., Cai, K., Fang, C., Ding, Q., Thijs, C., Blaak, E.E., Stehouwer, C.D.A., Xu, X., Yang, H., Wang, J., Wang, J., Jonkers, D.M.A.E., Masclee, A.A.M., Brix, S., Li, J., Arts, I.C.W. and Kristiansen, K., 2019. Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children. Microbiome 7: 2. https://doi.org/10.1186/s40168-018-0608-z
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 775 | 268 | 24 |
| PDF Views & Downloads | 729 | 270 | 25 |
Faecal microbial metabolites of proteolytic and saccharolytic fermentation in relation to degree of insulin resistance in adult individuals
In: Beneficial MicrobesSearch for other papers by M.A. González Hernández in
Current site
Google Scholar
PubMed
Search for other papers by E.E. Canfora in
Current site
Google Scholar
PubMed
Search for other papers by E.E. Blaak in
Current site
Google Scholar
PubMed
The gut microbiota may affect host metabolic health through microbial metabolites. The balance between the production of microbial metabolites by saccharolytic and proteolytic fermentation may be an important determinant of metabolic health. Amongst the best-studied saccharolytic microbial metabolites are the short-chain fatty acids acetate, propionate and butyrate. However, human data on the role of other microbial fermentation by-products in metabolic health are greatly lacking. Therefore, we compared in a cross-sectional study the faecal microbial metabolites (caproate, lactate, valerate, succinate, and the branched-chain fatty acids (BCFA) (isobutyrate, isovalerate)) between insulin sensitive (homeostatic model assessment of insulin resistance (HOMA-IR), HOMA-IR<1.85, IS) and insulin resistant (HOMA-IR>1.85, IR) individuals. Additionally, we assessed the relationships between faecal metabolites and markers of metabolic health including fasting glucose, insulin, free fatty acids, insulin resistance (HOMA-IR) and fasting substrate oxidation in 86 individuals with a wide range of body mass index. Faecal metabolite concentrations did not significantly differ between IS and IR. Furthermore, there were no associations between microbial metabolites and metabolic health markers, except for a slight positive association of isovalerate with carbohydrate oxidation (E%, std β 0.194, P=0.011) and fat oxidation (E%, std β -0.075, P=0.047), also after adjustment for age, sex and BMI. In summary, faecal caproate, lactate, valerate, succinate, and BCFA (isobutyrate, isovalerate) were not different between IR and IS individuals, nor was there any association between these faecal metabolites and parameters of metabolic health. Further human intervention studies are warranted to investigate the role of these microbially-derived fermentation products and their kinetics in metabolic health and insulin sensitivity.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 775 | 268 | 24 |
| PDF Views & Downloads | 729 | 270 | 25 |
